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Abstract
Objective To synthesise the evidence on the overall and differential
effects of interventions based on diet and physical activity during
pregnancy, primarily on gestational weight gain and maternal and
offspring composite outcomes, according to women’s body mass index,
age, parity, ethnicity, and pre-existing medical condition; and secondarily
on individual complications.
Design Systematic review and meta-analysis of individual participant
data (IPD).
Data sources Major electronic databases from inception to February
2017 without language restrictions.
Eligibility criteria for selecting studies Randomised trials on diet and
physical activity based interventions in pregnancy.
Data synthesisStatistical models accounted for clustering of participants
within trials and heterogeneity across trials leading to summary mean
differences or odds ratios with 95% confidence intervals for the effects
overall, and in subgroups (interactions).
Results IPD were obtained from 36 randomised trials (12 526 women).
Less weight gain occurred in the intervention group than control group
(mean difference −0.70 kg, 95% confidence interval −0.92 to −0.48 kg,
I2=14.1%; 33 studies, 9320 women). Although summary effect estimates
favoured the intervention, the reductions in maternal (odds ratio 0.90,
95% confidence interval 0.79 to 1.03, I2=26.7%; 24 studies, 8852 women)
and offspring (0.94, 0.83 to 1.08, I2=0%; 18 studies, 7981 women)
composite outcomes were not statistically significant. No evidence was
found of differential intervention effects across subgroups, for either
gestational weight gain or composite outcomes. There was strong
evidence that interventions reduced the odds of caesarean section (0.91,
0.83 to 0.99, I2=0%; 32 studies, 11 410 women), but not for other
individual complications in IPD meta-analysis. When IPD were
supplemented with study level data from studies that did not provide
IPD, the overall effect was similar, with stronger evidence of benefit for
gestational diabetes (0.76, 0.65 to 0.89, I2=36.8%; 59 studies, 16 885
women).
Conclusion Diet and physical activity based interventions during
pregnancy reduce gestational weight gain and lower the odds of
caesarean section. There is no evidence that effects differ across
subgroups of women.
Introduction
Half of all women of childbearing age worldwide are overweight
or obese.1 2 3 Obesity and excessive gestational weight gain put
mother and offspring at risk, both in pregnancy and in later
life.4 5 6 The resultant costs to the health service and society are
considerable.7 8 Increasingly, healthcare organisations and
research funding bodies prioritise research on interventions and
strategies to reduce maternal weight related adverse outcomes
in pregnancy.9 10 11 12
Syntheses of study level data on effects of diet and physical
activity based interventions in pregnancy13 have shown an
overall benefit on limiting gestational weight gain, but the
findings varied for their protective effect on maternal and
offspring outcomes.13 14 Importantly, the subgroups of women
who may benefit the most from such interventions are not
known.15 For this, primary studies do not have sufficient
power,16 17 and meta-analyses of study level data are limited by
the absence of published details of subgroup effects,18 and by
potential ecological bias.19 These problems can be addressed by
evidence synthesis using raw individual level data from relevant
studies.20 21
We undertook an individual participant data (IPD)meta-analysis
to assess the effects of diet and physical activity based
interventions, primarily on gestational weight gain and on
maternal and offspring composite outcomes, in subgroups
defined by body mass index (BMI), age, parity, ethnicity, and
pre-existing medical condition. Furthermore, we assessed the
overall effects, and those of individual interventions (diet,
physical activity, mixed), on critically important maternal and
offspring complications. In addition to using IPD, we also
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assessed the impact of incorporating study level data from other
studies not providing IPD.
Methods
The IPD meta-analysis was performed using a prespecified
protocol (PROSPERO CRD42013003804)22 and was reported
in line with recommendations of the Preferred Reporting Items
for Systematic reviews and Meta-Analysis of Individual
Participant Data (PRISMA-IPD).23
Literature search and study identification
We searched the major electronic databases Medline, Embase,
Cochrane Database of Systematic Reviews, Database of
Abstracts of Reviews of Effects, Cochrane Central Register of
Controlled Trials, and Health Technology Assessment Database
fromOctober 2013 toMarch 2015 to update our previous search
in this topic for randomised trials on diet and physical activity
based interventions in pregnancy.13 The search was further
updated in January 2016 and February 2017 to identify new
studies. We searched the internet by using general search
engines, and contacted researchers in the specialty to identify
relevant trials. There were no language restrictions. Web
appendix 1 provides details of the search strategy.
Two independent researchers (ER and NM, AAM, or EM)
selected studies in a two stage process. In the first stage,
potential citations were identified. Next, we did a detailed
evaluation of the full manuscripts of potential papers and
selected articles that fulfilled the eligibility criteria. We included
randomised trials that assessed the effects of interventions based
on diet, physical activity, and mixed interventions in pregnancy,
on maternal and offspring outcomes. We classified complex
interventions on diet and physical activity, including those with
behavioural change components, as mixed interventions. We
excluded studies that only included women with gestational
diabetes at baseline, involved animals, reported only non-clinical
outcomes, and were published before 1990. The primary
outcomes were gestational weight gain, a composite of maternal
outcomes, and a composite of offspring outcomes. The
secondary outcomes were individual maternal and offspring
complications. The components of the composite outcomes
were determined by a two round Delphi survey of researchers
in this specialty, and were considered to be critically important
to clinical practice.24 The maternal composite outcome included
gestational diabetes mellitus, hypertensive disorders of
pregnancy, preterm delivery, and caesarean section. The
offspring composite outcome included stillbirth, small for
gestational age fetus, large for gestational age fetus, and
admission of the newborn to a neonatal intensive care unit.
We defined gestational weight gain as the difference between
maternal weight at antenatal booking and the last weight
measured before delivery. We accepted the primary authors’
definition and reporting of gestational diabetes mellitus,
pregnancy induced hypertension, pre-eclampsia, caesarean
section, stillbirth, and admission to a neonatal intensive care
unit. We defined preterm delivery as birth before 37 weeks of
gestation, and small for gestational age and large for gestational
age as babies with a birth weight below the 10th and at or over
the 90th centiles, respectively, adjusted for mother’s BMI, parity,
and gestational age at delivery.25
Establishment of IPD collaborative network and database—We
established the InternationalWeight Management in Pregnancy
IPD Collaborative Group by contacting researchers of eligible
studies.26A bespoke database was developed, and we requested
collaborators for relevant data in any format. We sent three
reminders when there was no response.
Quality assessment of the included studies
Two independent reviewers assessed the quality of the
randomised trials using a risk of bias tool for sequence
generation, allocation concealment, blinding, incomplete
outcome data, selective outcome reporting, and other potential
sources of bias.27 We considered a study to have a high risk of
bias if it scored as such in at least one of the following domains:
randomisation, allocation concealment, blinding of outcome
assessment, or incomplete outcome data; all items should be
scored as low risk for a study to be classified as low risk of bias.
Data extraction and assessment of IPD
integrity
Two independent reviewers (ER and NM) undertook data
extraction at study level for inclusion and exclusion criteria, the
characteristics of the intervention, and the reported outcomes.
We sought to obtain IPD from relevant studies published until
July 2015, which was the endpoint for IPD acquisition, to allow
sufficient time for data cleaning, standardisation, and
amalgamation of datasets.We also extracted the published study
level data for all relevant studies published until February 2017,
including those published beyond the individual data acquisition
timeline, and those for which IPD were not provided by study
authors.
We obtained IPD for individual maternal characteristics that
were determined a priori, such as BMI, age, parity, ethnicity,
socioeconomic status, and pre-existing medical conditions.
Continuous variables were kept continuous, but somewere also
categorised when considered to be clinically useful. These
included categorisations based on BMI (normal 18.5-24.9 kg/m2,
overweight 25-29.9 kg/m2, obese ≥30 kg/m2) and age (cut-off
20 years). Mother’s ethnicity was classified as white or
non-white. We used the mother’s educational status to indicate
socioeconomic status: low status if the mother did not complete
secondary education to A level, medium if she completed
secondary education (A level equivalent), and high if she
completed any further higher education.We defined pre-existing
medical conditions as diabetes mellitus, early onset of
gestational diabetes, or hypertension.
We considered participants to be adherent to the intervention
based on the following criteria: completion of at least 70% of
the intervention protocol, dataset provided information on
adherence in a yes or no format, or participant was deemed to
be adherent as per the study criteria. We performed range and
consistency checks on all IPD and produced summary tables.
The randomisation ratio, baseline characteristics, and method
of analysis in the IPD dataset were compared with the published
information. Any discrepancies, missing data, obvious errors,
and inconsistencies between variables or outlying values were
queried and rectified as necessary with input from the original
authors.
Data synthesis
To obtain summary estimates (mean difference for gestational
weight gain and odds ratios for binary outcomes) and 95%
confidence intervals for the intervention effects for each primary
outcome we undertook a two stage IPD meta-analysis.21 We
assessed the effects across all interventions overall and for
individual interventions. A two stage IPD meta-analysis was
used to obtain summary estimates of the subgroup effects
(interactions) of interest, which compared differential effects
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of interventions across the primary outcomes. Additionally we
evaluated whether there are any differential effects of
interventions for individual complications, according to BMI
(normal, overweight, obese). All analyses were designed to
preserve the intention to treat principle.
The first stage of the two stage meta-analysis involved analysing
the IPD in each trial separately, to account for the clustering of
participants within trials, and to obtain the estimates of interest
and their variances. For the cluster randomised trials, we
included a random intercept for a unit of randomisation to
account for this further clustering. For the outcome of gestational
weight gain, we used analysis of covariance in each trial to
regress the final weight value against the intervention while
adjusting for baseline weight and centres in cluster randomised
trials. For maternal and offspring outcomes, we used a logistic
regression model for each trial separately, with the intervention
as a covariate. We excluded women with confirmed glucose
intolerance or a hypertensive disorder at baseline, as defined by
the primary authors, in the analysis of composite adverse
pregnancy outcomes. To assess potential intervention effect
modifiers, we extended the aforementioned models to include
interaction terms between participant level covariates and the
intervention (ie, treatment-covariate interaction terms).
In the second stage, we pooled the derived effect estimates (ie,
treatment effects or treatment-covariate interactions) across
trials using a random effects model fitted using restricted
maximum likelihood. The random effects approach allowed us
to account for unexplained interstudy heterogeneity in effects
across studies. This produced summary estimates and 95%
confidence intervals for the intervention effects and the
interactions (subgroup effects). The Hartung-Knapp correction
was applied when subsequently deriving 95% confidence
intervals for the true mean effect, to help account for the
uncertainty of the estimate of interstudy heterogeneity.28 29
We included studies that did not contribute IPD, by
incorporating their extracted study level data within the second
stage of the IPD meta-analysis framework, to obtain summary
estimates of intervention effects that combined IPD and non-IPD
studies. Sensitivity analyses were also performed by excluding
studies with high risk of bias, analysing the primary outcomes
separately for each intervention type (diet, physical activity,
and mixed), excluding participants not adherent to the
intervention, by analysing change in BMI instead of weight
gain, and excluding maternal weight gain estimates from
pregnancies that ended before 37 completed weeks of gestation
to avoid systematic differences.
Heterogeneity was summarised using the I2 statistic, the
estimated interstudy variance (τ2),30 and approximate 95%
prediction intervals, which indicate the potential intervention
(or interaction) effect in a new population similar to those
included in the meta-analysis.31
Small study effects (potential publication bias) were investigated
by using contour enhanced funnel plots alongside visual
examination and statistical tests for asymmetry (Egger’s test
for continuous outcomes or Peter’s test for binary outcomes).32
We assessed for IPD availability bias by comparing the summary
results when including non-IPD studies with those from IPD
studies.33 Furthermore, we compared the symmetry of funnel
plots before and after inclusion of non-IPD studies. All
meta-analyses were undertaken using Stata software version
12.1 (StataCorp, College Station, TX, USA), and statistical
significance was considered at the 5% level.
Patient involvement
No patients were involved in setting the research question or
the outcome measures, nor were they involved in developing
plans for recruitment, design, or implementation of the study.
A patient representative provided an input to the interpretation
and writing up of results. There are no plans to disseminate the
results of the research to study participants or the relevant patient
community. It was not evaluated whether the studies included
in the review had any patient involvement.
Results
Study selection
We identified 58 trials published up to June 2015, of which 36
studies (62%) provided individual participant data
(IPD),16 17 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66
that accounted for data from 80% of the participants (12 526/15
541); 22 studies (3015 women) did not provide IPD (fig
1⇓).67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 A further 45
trials (9945
women)8990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133
were identified after the IPD acquisition timeline until February
2017.
Characteristics of included studies and
participants
IPD were available from 36 trials in 16 countries. Twenty two
studies17 34 36 37 38 39 41 42 47 48 51 52 53 56 57 58 59 60 61 62 63 67 were from
Europe, four each fromNorth America,44 54 65 66Australia,16 43 45 50
and Brazil,35 49 55 64 and one study each from Egypt40 and Iran.46
Twenty three IPD studies included women of any body mass
index (BMI),34 35 36 37 38 42 44 45 46 47 48 52 54 55 56 58 59 60 61 64 65 66 67 seven
included only obese women,17 39 40 41 50 62 63 and six included obese
and overweight women.16 43 49 51 53 57 The interventions included
those mainly based on diet (four IPD studies)47 61 62 64 or physical
activity (16 IPD studies),35 36 37 42 46 49 50 51 52 55 58 59 65 66 69 and those
based on a mixed approach of diet, physical activity, or
behaviour modifying techniques, or all three together (15 IPD
studies).16 17 34 39 40 41 43 44 45 48 53 54 56 60 63 One study had a three arm
design with intervention arms being physical activity only and
a mixed approach.57 The web appendix provides the
characteristics of all IPD studies, and also those that did not
contribute IPD.
More than 80% of women in the IPD meta-analyses were of
white origin, and at least half were classified as of high
socioeconomic status. Around 45% of womenwere nulliparous,
40% were obese, and a similar proportion was classified as
having sedentary status with no exercise at baseline (table 1⇓).
IPD were available to assess the effects of interventions on
gestational weight gain (33 studies, 9320 women), maternal
composite outcomes (24 studies, 8852 women), and offspring
composite outcomes (18 studies, 7981 women). The largest IPD
were available for the outcome of large for gestational age fetus
(34 studies, 12 047 women), followed by preterm delivery (32
studies, 11 676 women), small for gestational age fetus (33
studies, 11 666 women), any caesarean section (32 studies, 11
410 women), hypertensive disorders of pregnancy (22 studies,
9618 women), and gestational diabetes (27 studies, 9427
women). We did not have access to IPD for 51% of all eligible
women (12 960/25 486) from 67 studies (fig 1⇓).
Quality of included studies
Overall, trials had a low risk of bias in random sequence
generation (71%, 73/103). More than 90% (34/36) of studies
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that contributed to the IPD were assessed as low risk of bias in
this domain compared with 58% (28/67) of the non-IPD studies.
Two IPD studies (2/36) and one non-IPD study (3/67) were
considered high risk for allocation concealment. Blinding of
outcome assessment was appropriate in 44% (16/36) of IPD
and 33% (22/67) of non-IPD studies (fig 2⇓). Fewer IPD studies
(5/36) were assessed as high risk of bias for incomplete outcome
data than non-IPD studies (15/67). Figure 2⇓ shows the summary
of the risk of bias estimates for all eligible studies and those
that did and did not contribute to IPD. We did not encounter
any issues that we were not able to clarify with the IPD
contributor during the IPD integrity check.
Effects of interventions on pregnancy
outcomes
Gestational weight gain
Based on IPDmeta-analysis (33 studies, 9320 women), diet and
physical activity based interventions resulted in significantly
less gestational weight gain compared with control (summary
mean difference −0.70 kg, 95% confidence interval −0.92 to
−0.48 kg, I2=14.1%), after adjusting for baseline weight and
clustering. The approximate 95% prediction interval for the
intervention effect in a new setting was −1.24 to −0.16 kg (table
2⇓).
Differential effects in subgroups
No strong evidence was found of a treatment-covariate
interaction for baseline BMI when treated as a continuous
covariate (−0.02 kg change in intervention effect per one unit
increase in BMI, 95% confidence interval −0.08 to 0.04 kg), or
when compared as overweight versus normal (−0.11 kg, −0.77
to 0.55 kg), obese versus normal (0.06 kg, −0.90 to 1.01 kg),
and obese versus overweight (−0.09 kg, −1.05 to 0.86 kg). We
also did not observe evidence of a subgroup effect for age (−0.03
kg per one year increase in age, 95% confidence interval −0.08
to 0.02 kg), parity (0.10 kg change in effect for multiparity
versus nulliparity, 95% confidence interval −0.39 to 0.60 kg),
ethnicity (0.05 kg change in effect for non-white versus white,
95% confidence interval −1.27 to 1.37 kg), and underlying
medical condition (1.51 kg change in effect for women with at
least one condition versus none, 95% confidence interval −2.01
to 5.02 kg). The findings were consistent when continuous
covariates were analysed as categorical measures based on
clinically relevant cut points (table 3⇓).
Sensitivity analyses
The reduction in gestational weight gain owing to the
intervention was consistently observed when the analysis was
restricted to studies with low risk of bias (−0.67 kg, 95%
confidence interval −0.95 to −0.38 kg; 15 studies, 5585women),
women adherent to the intervention (−0.76 kg, −1.00 to −0.52
kg; 33 studies, 8565 women), women followed up until more
than 37 weeks’ gestation (−0.91 kg, −1.17 to −0.66 kg; 28
studies, 5324 women), and for BMI instead of maternal weight
as an outcome (−0.30 kg/m2, −0.39 to −0.21 kg/m2; 31 studies,
9238 women).
Addition of studies that did not contribute IPD
In meta-analysis undertaken by supplementing the IPD with
study level data from studies (48 studies, 8210 women) that did
not contribute IPD, we observed a larger beneficial intervention
effect for weight gain (summary mean difference −1.1 kg; 95%
confidence interval −1.46 to −0.74 kg; 81 studies, 17 530
women). The benefit was also consistently observed for
individual interventions based on diet, physical activity, or
mixed approach (table 2⇓).
Maternal and offspring composite outcomes
In the IPD meta-analyses, the summary estimates favoured the
intervention group for reduction in odds of maternal (odds ratio
0.90, 95% confidence interval 0.79 to 1.03, I2=26.7%; 24 studies,
8851 women) and offspring composite outcomes (0.94, 0.83 to
1.08, I2=0%; 18 studies, 7981 women), but these were not
statistically significant (table 4⇓).
Differential effects across subgroups
We observed no strong evidence of differential subgroup effects
for maternal composite outcome according to either baseline
BMI (treatment-covariate interaction 1.00, 95% confidence
interval 0.98 to 1.02), age (1.01, 0.99 to 1.03), parity (1.03, 0.75
to 1.39), ethnicity (0.93, 0.63 to 1.37), and underlying medical
condition (1.44, 0.15 to 13.74) (table 5⇓).
A similar lack of differential effect was observed for offspring
composite outcome in mothers grouped according to baseline
BMI (interaction 0.98, 95% confidence interval 0.95 to 1.00),
age (1.01, 0.98 to 1.04), parity (0.94, 0.64 to 1.37), ethnicity
(1.12, 0.75 to 1.68), and underlying medical condition (0.58,
0.03 to 9.81) (table 4⇓). The findings did not change for maternal
and offspring composite outcomes when BMI and age were
analysed as continuous instead of categorical variables.
Individual maternal outcomes
Overall, in the IPD meta-analysis we observed a significant
reduction in caesarean section (odds ratio 0.91, 95% confidence
interval 0.83 to 0.99, I2=0%; 32 studies, 11 410 women) for
interventions compared with routine care. The reduction in other
individual outcomes such as gestational diabetes (0.89, 0.72 to
1.10, I2=23.8%; 27 studies, 9427women), hypertensive disorders
of pregnancy (0.95, 0.78 to 1.16, I2=24.2%; 22 studies, 9618
women), and preterm delivery (0.94, 0.78 to 1.13, I2=17.3%;
32 studies, 11 676 women) were not statistically significant in
IPD meta-analyses (table 5⇓). We did not observe any
differential effect according to baseline BMI category (normal,
overweight, obese) for any of the individual maternal outcomes
(see web appendix 3). The findings were consistent when study
level data from non-IPD studies were meta-analysed with IPD,
but with a stronger evidence of benefit for gestational diabetes.
The reduction in gestational diabetes (0.76, 0.65 to 0.89, 36.8%;
59 studies, 16 885 women) became significant (table 5⇓).
Among individual interventions, those basedmainly on physical
activity showed a reduction in gestational diabetes in both IPD
(odds ratio 0.67, 95% confidence interval 0.46 to 0.99, I2=0%;
10 studies, 2700 women) and in combined (IPD and non-IPD)
meta-analyses (0.66, 0.53 to 0.83, I2=0%; 27 studies, 6755
women). While the summary estimates for physical activity
based interventions favoured caesarean section (0.82, 0.67 to
1.01, I2=0%; 13 studies, 3046 women) and hypertensive
disorders of pregnancy (0.74, 0.42 to 1.33, I2=6.0%; 7 studies,
2565 women) in IPD meta-analyses, the addition of non-IPD
studies resulted in stronger evidence of benefit for these
complications, with reduction in the respective odds by 17%
(0.83, 0.73 to 0.95, I2=0%; 32 studies, 6587 women) and 32%
(0.68, 0.49 to 0.93, I2=0%; 20 studies, 5125 women).
A strong effect was observed for preterm birth with diet based
interventions in both IPD (odds ratio 0.28, 95% confidence
interval 0.08 to 0.96, I2=0%; 4 studies, 1344 women) and
combined analyses (0.32, 0.14 to 0.70, I2=0%; 7 studies, 1696
women), but the overall sample sizes were relatively small (table
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5⇓). There was no evidence of benefit with mixed interventions
for any maternal outcomes.
Individual offspring outcomes
No strong evidence was found that interventions had an effect
on individual offspring outcomes such as stillbirth (odds ratio
0.81, 95% confidence interval <0.001 to 256.69, I2=0%; 2
studies, 3719 women), small for gestational age fetus (1.06,
0.94 to 1.20, I2=0%; 33 studies, 11 666 women), large for
gestational age fetus (0.90, 0.76 to 1.07, I2=38.0%; 34 studies,
12 047 women), and admission to a neonatal intensive care unit
(1.01, 0.84 to 1.23, I2=0%; 16 studies, 8140 women) based on
the IPD meta-analyses. The significance of the findings did not
change when non-IPD studies were added to the IPD
meta-analyses (table 5⇓). The numbers of eligible participants
for whom data were obtained, effect estimates, and confidence
intervals for all above analyses are available from the study
authors on request. There was no differential effect for any
individual offspring outcome according to the BMI category
(see web appendix 3).
Small study effects
We found visual and statistical evidence (Egger’s test P=0.04)
of small study effects in the contour enhanced funnel plots for
the IPDmeta-analysis of the overall effect on gestational weight
gain. The asymmetry of the plot was not improved by the
addition of study level data from non-IPD studies to the
meta-analysis. When studies with high risk of bias were
excluded from the analysis, the symmetry of the funnel plot
improved (Egger’s test P=0.61).We found significant evidence
of small study effects for the maternal composite outcome
(Peter’s test P=0.04), but not for the offspring composite
outcome (P=0.85) (see web appendix 4).
Discussion
Our large, collaborative individual participant data (IPD)
meta-analysis confirms that diet and physical activity based
interventions in pregnancy reduce gestational weight gain. This
beneficial effect was consistently observed irrespective of
maternal body mass index (BMI), age, parity, ethnicity, or
pre-existing medical condition; and remained when studies at
high risk of bias were excluded. The findings are generalisable,
with the 95% prediction interval suggesting a beneficial effect
on gestational weight gain when the intervention is applied in
a new population or setting. There is no strong evidence that
interventions reduce the risk ofmaternal and offspring composite
outcomes, with no variation in effect observed across the
subgroups.
For individual outcomes, interventions reduce caesarean section
without a statistically significant reduction in other maternal
and offspring complications. The effects of interventions for
individual maternal and offspring complications are consistent
irrespective of the BMI of the mother. Addition of study level
data from non-IPD studies to the IPD meta-analysis increased
the precision of estimates, without a change in the direction of
effect, and showed additional benefit for gestational diabetes.
Among individual interventions, those mainly based on physical
activity lowered the odds of gestational diabetes.
Strengths and weaknesses of this study
To our knowledge this is the first IPD meta-analysis to assess
the differential effects of diet and physical activity based
interventions for important, clinically relevant outcomes, in
subgroups of womenwhowere identified a priori. Establishment
of the International Weight Management in Pregnancy IPD
Collaborative Group facilitated the collaboration of key
researchers in this area and provided access to the largest IPD
in this specialty. This allowed us to extract data that were not
published, with larger sample sizes for outcomes such as preterm
birth, small and large for gestational age fetuses, and admission
to the neonatal intensive care unit for IPD than for study level
meta-analysis. Furthermore, we were able to minimise the
heterogeneity in the population by excluding individual women
who did not fulfil the inclusion criteria.We compared the quality
of studies that contributed to the IPD, which were generally of
higher quality than those that did not contribute IPD.
Access to IPD provided us with substantially increased power
(compared with individual trials) to robustly estimate treatment
covariate interactions and to avoid the ecological bias observed
in aggregate metaregression of study level covariates.19 21 It also
allowed us to adjust for baseline weight using analysis of
covariance in each trial,134 which is the best approach to
analysing continuous outcomes,135 although rarely used in
individual trials. Our reporting of 95% prediction intervals for
the overall and differential effects of interventions across
subgroups allowed us to quantify the range of effects across
populations of interest.
The subgroups were chosen in response to the call by the
National Institute for Health and Care Excellence for assessment
of the effectiveness of lifestyle interventions in pregnancy for
specific groups of women considered to be at high risk of
complications, such as teenagers, those from ethnic minorities,
and women who enter pregnancy obese.15 We assessed
treatment-covariate interactions for subgroups as both
continuous and categorical variables. We chose 20 years as the
cut-off for age, as it allowed us to assess the effect of
intervention in young adults, where pregnancymay alter normal
growth processes and increase the women’s risk of becoming
overweight or obese.136 Adolescent mothers also retain more
weight post partum than mature control participants.136
Owing to the variation in reporting, wewere only able to broadly
classify the ethnicity of women as white or non-white. Our
findings were limited by the smaller number of non-white
comparedwith whitemothers.We combined diet based, physical
activity based, and mixed approach interventions to provide an
overall estimate, and also reported their individual effects.13 137
Since more than one clinical outcome is considered to be
important to clinical care, we assessed the effects of
interventions on maternal and offspring composite outcomes,
the individual components of which were identified through a
robust Delphi process.24 The varying definitions may have an
impact on findings for gestational diabetes and pre-eclampsia,
where the cut-offs and the criteria for diagnosis differed. Another
limitation is that the majority of our population has a medium
to high education status, a factor favouring compliance with
interventions.
IPD repository
By establishing the International Weight Management in
Pregnancy IPD live repository through the support of the
individual research teams, we ensured that in addition to the
standardisation, data were robustly safeguarded. The continuing
growth of the repository is crucial for future research in this
area138 and will accelerate update of the meta-analysis for the
various relevant outcomes as new studies are published. We
were successful in obtaining individual data from 80% of all
participants within the IPD acquisition timeline. While every
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effort was made to include IPD from the latest studies identified
in the updated search, we were limited by the time needed to
prepare the IPD datasets, which involved data access, setting
up of institutional contracts, cleaning and formatting of accessed
data, resolution of queries with individual researchers, and
standardisation and merging of the data. This restricted our
ability to include studies published after the agreed data
acquisition timeline in the IPD meta-analysis. In a high priority
area such as obesity and weight gain in pregnancy, the number
of published studies has increased rapidly, with at least 10 trials
published each year since 2011, and 16 published in 2016. We
sought to maximise the information needed to inform the
findings by combining study level data from non-IPD studies
with the IPD meta-analyses. The conclusions appeared to be
robust for nearly all outcomes. Furthermore, the non-availability
of IPD from these studies did not appear to contribute to the
observed small study effects, since the asymmetry of the funnel
plot was not altered when the non-IPD studies were added.
Non-IPD studies were also generally at a higher risk of bias.
Gestational weight gain
Diet and physical activity based interventions reduce gestational
weight gain. We have shown that this beneficial effect is
observed in all women irrespective of maternal characteristics.
The findings are consistent for any type of intervention, even
when restricted to only high quality studies and to women
adherent to the intervention, and when non-IPD are added to
IPD. Mothers with excess weight gain in pregnancy are at
increased risk of postpartum weight retention.139 This increase
in interpregnancy BMI may contribute to risks of entering
subsequent pregnancies as overweight or obese, with adverse
outcomes in subsequent pregnancy.140 Furthermore, this may
increase women’s risk of cardiovascular morbidity andmortality
in later life.141Comparedwith published evidence,13we identified
a smaller reduction in gestational weight gain of 0.7 kg with
interventions. The effect of such a reduction in gestational
weight gain (compared with routine care) on postpartumweight
retention and long term outcomes is not known.
Maternal and offspring outcomes
Despite the summary effect estimates favouring the interventions
for maternal and offspring composite outcomes, these were not
statistically significant. Interventions significantly reduced the
odds of caesarean section. Previous systematic reviews showed
a trend towards reduction in this risk overall, and for individual
interventions (diet, physical activity, or mixed approach),13 but
were limited by the small sample sizes and paucity of reporting,
compared with the 11 000 women included in our IPD
meta-analysis. Of the individual interventions, physical activity
in pregnancy showed a trend towards reduction in caesarean
section in IPD meta-analysis, which became statistically
significant with minimal heterogeneity when non-IPD were
added. The physical activity component in most studies involved
a structured exercise of moderate intensity (eg, aerobic classes
or stationary cycling) with resistance training that varied in
frequency (see web appendix 5). The relatively small numbers
of women in the diet only intervention may have contributed
to the imprecision in estimates.
Although the direction of effect appeared to favour the
intervention for other maternal outcomes, they were not
statistically significant. Addition of non-IPD to the IPD
meta-analysis resulted in a statistically significant reduction in
gestational diabetes. However, unlike our IPD analysis, we were
not able to implement the strict inclusion and exclusion criteria,
standardise the analysis strategy (eg, adjust for baseline), or
ascertain occurrence of outcome in the combined analysis with
study level data. Physical activity based interventions
statistically significantly reduced the odds of gestational diabetes
in IPD meta-analysis, and also when combined with non-IPD.
This benefit could bemediated throughmechanisms that resulted
in improved glycaemic variables and outcomes in type 4 and
type 2 diabetes, through increased insulin sensitivity and reduced
oxidative stress. Exercise in pregnancymay also have a potential
role in preventing hypertensive disorders of pregnancy. The
effects of diet and physical activity on maternal and offspring
outcomes did not vary according to the BMI of the woman,
highlighting the potential benefits for all and not selected groups
of mothers.
Interventions based on diet showed a reduction in preterm birth,
although the analysis included relatively small numbers of
women. We did not identify any benefits with interventions in
preventing any adverse offspring outcome, despite a sample
size that was twofold to threefold more than published data for
some outcomes, consistent with previous findings.14 The lack
of adverse effects such as small for gestational age and preterm
birth with diet and physical activity in pregnancy should reassure
mothers who have traditionally been advised not to undertake
structured exercise or manage their diet in pregnancy.
Implications for clinical practice
Currently in the UK, only obese women are offered access to a
dietician and specific antenatal classes for advice on diet and
lifestyle, to minimise gestational weight gain. Based on our
work, it is likely that women of all BMI groups could benefit
from specific advice on diet and physical activity for weight
gain, and some maternal outcomes. Healthcare professionals
should avoid variations in care and lifestyle advice provided to
mothers based on ethnicity, age, and underlying medical
conditions, as no differential effects were found.
Discussions about diet and physical activity in pregnancy, which
are delivered as part of antenatal care, should incorporate
specific estimates of benefit for caesarean section and gestational
weight gain, and the likelihood of preventing gestational
diabetes. Mothers should be reassured about the safety of the
interventions, particularly on physical activity and structured
exercise in pregnancy, by highlighting the benefits and lack of
harm. This may improve engagement and compliance with the
intervention. Importantly, such interventions in pregnancy could
be considered in global efforts to reduce caesarean section in
relevant populations.
Implications for further research
Whether the observed benefit in gestational weight gain with
diet and physical activity translates to long term benefits to the
mother and child needs to be assessed. Evaluation of any
differential effects according to the individual components of
the intervention, such as duration, frequency, provider, and
setting, on individual outcomes is required to provide detailed
recommendations. The effects of these interventions onmothers
in low and middle income countries, particularly in those
countries with high rates of caesarean section and gestational
diabetes, need to be ascertained from large randomised trials.
There is a need to develop a harmonised core outcome set for
future reporting of clinical trials in this area, to maximise the
meaningful interpretation of published data. This is particularly
relevant for rare but important outcomes such as shoulder
dystocia, birth trauma, and venous thromboembolic events.
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Conclusion
Diet and physical activity based interventions in pregnancy limit
gestational weight gain, with no evidence that this effect differs
across subgroups defined by maternal characteristics. The odds
for caesarean section are also reduced.
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Tables
Table 1| Baseline characteristics of women included in studies that contributed to the meta-analysis of individual participant data on diet
and physical activity based interventions in pregnancy. Values are numbers (percentages*) unless stated otherwise
ControlInterventionNo of studies (No of women)Characteristics
30.1 (5.2)30.0 (5.1)35 (12 006)Mean (SD) age (years)
34 (12 031)Weight (body mass index):
1842 (31.8)1974 (31.7)Normal (18.5-24.9 kg/m2)
1523 (26.3)1578 (25.3)Overweight (25-29.9 kg/m2)
2434 (42.0)2680 (43.0)Obese (≥30 kg/m2)
27 (10 020)Race/ethnicity:
4217 (87.2)4562 (88.0)White (including Russians and Australians)
156 (3.2)157 (3.0)Asian
292 (6.0)292 (5.6)Black
64 (1.3)67 (1.3)Central and South American
37 (0.8)37 (0.7)Middle Eastern (including Iranian and Turkish)
68 (1.4)71 (1.4)Other
29 (8914)Educational status of mother†:
724 (16.9)722 (15.6)Low
1292 (30.2)1372 (29.6)Medium
2268 (52.9)2536 (54.8)High
865 (16.4)875 (15.4)29 (10 958)Smoker
33 (11 805)Parity:
2692 (47.3)3027 (49.5)0
2083 (36.6)2136 (34.9)1
634 (11.1)647 (10.6)2
165 (2.9)179 (2.9)3
113 (2)129 (2.1)≥4
1731 (47.6)1761 (44.6)27 (7583)No exercise or sedentary
9 (0.2)6 (0.1)25 (9589)Pre-existing diabetes mellitus
54 (2.1)73 (2.5)23 (5494)Pre-existing hypertension
*Proportion out of observations in control or intervention arms, respectively.
†Low=not completed secondary education to A level; medium=completed secondary education (A level equivalent); high=any further or higher education.
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Table 2| Effects of diet and physical activity based interventions on gestational weight gain summarised using individual participant data
(IPD) alone, and by supplementing IPDwith study level data from studies that did not contribute IPD. Values aremeans (standard deviations)
unless stated otherwise
I2 (%)Mean difference (95% CI)ControlInterventionNo of studies (No of women)Outcomes
IPD and
non-IPD
IPDIPD and non-IPDIPDIPD and
non-IPD
IPDIPD and
non-IPD
IPDIPD and
non-IPD
IPD
73.814.1−1.10 (−1.46 to
−0.74)
−0.70 (−0.92 to
−0.48)
11.5*10.8 (5.4)10.6*10.1 (5.4)81 (17 530)33 (9320)Overall
92.30.0−2.84 (−4.77 to
−0.91)
−0.72 (−1.48 to
0.04)
11.7*11.0 (4.8)9.2*10.2 (4.4)12 (2017)4 (1168)Diet
45.40.0−0.72 (−1.04 to
−0.41)
−0.73 (−1.11 to
−0.34)
11.9*10.8 (4.8)11.3*9.8 (4.4)37 (7355)15 (2915)Physical
activity
54.634.9−1.00 (−1.39 to
−0.61)
−0.71 (−1.10 to
−0.31)
11.0*10.6 (5.9)10.3*10.2 (6.0)35 (8448)15 (5369)Mixed
approach
*Recalculation using DerSimonian-Laird.
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Table 3| Differential effects of diet and physical activity based interventions on gestational weight gain in subgroups of pregnant women
Treatment covariate interactionMean difference* kg (95% CI)No of studies (No of women)Maternal characteristics
I2 (%)Coefficient; 95% CI (95% PI)
Baseline body mass index:
39.8−0.02; −0.08 to 0.04 (−0.21 to 0.17)†−0.77 (−1.15 to −0.39)21 (3376)Normal
−0.75 (−1.22 to −0.27)28 (2574)Overweight
−0.85 (−1.41 to −0.29)31 (3335)Obese
Parity:
4.80.10; −0.39 to 0.60 (−0.83 to 1.04)‡−0.80 (−1.17 to −0.43)27 (4513)Nulliparous
−0.62 (−0.88 to −0.37)27 (4548)Multiparous
Ethnicity:
26.10.05; −1.27 to 1.37 (−1.28 to 1.39)§−0.74 (−1.07 to −0.42)21 (6814)White
−0.42 (−1.12 to 0.28)15 (621)Non-white
Age (years):
25.9−0.03; −0.08 to 0.02 (−0.14 to 0.09)¶−0.72 (−0.95 to −0.50)32 (9045)≥20
0.05 (−1.34 to 1.44)13 (232)<20
Pre-existing medical conditions**:
28.41.51; −2.01 to 5.02 (−4.13 to 7.15)††−0.62 (−0.90 to −0.34)18 (4335)None
0.40 (−1.92 to 2.71)6 (128)≥1
PI=prediction interval.
*Model accounted for baseline weight and clustering effect.
†Per unit of body mass index.
‡Multiparous versus nulliparous.
§Non-white versus white.
¶Per year of age.
**Diabetes mellitus or hypertension.
††≥1 medical condition versus none.
Open Access: Reuse allowed Subscribe: http://www.bmj.com/subscribe
BMJ 2017;358:j3119 doi: 10.1136/bmj.j3119 (Published 19 July 2017) Page 13 of 18
RESEARCH
Table 4| Effects of diet and physical activity based interventions on pregnancy outcomes summarised using individual participant data
(IPD) alone, and by supplementing IPD with study level data from studies that did not contribute IPD
I2 (%)Odds ratio (95% CI)Control: event/No eventIntervention: event/No
event
No of studies (No of
women)
Outcomes
IPD and
non-IPD
IPDIPD and
non-IPD
IPDIPD and
non-IPD
IPDIPD and
non-IPD
IPDIPD and
non-IPD
IPD
Maternal
Composite
outcome:
NA26.7NA0.90 (0.79 to
1.03)
NA1837/2390NA1896/2728NA24 (8851)Overall
NA0.0NA0.60 (0.20 to
1.75)
NA84/134NA42/137NA3 (397)Diet
NA10.8NA0.81 (0.61 to
1.09)
NA367/748NA346/850NA9 (2311)Physical activity
NA34.9NA0.97 (0.84 to
1.12)
NA1438/3009NA1508/1742NA13 (6259)Mixed approach
Gestational
diabetes:
36.823.80.76 (0.65 to
0.89)
0.89 (0.72 to
1.10)
1046/7101571/3939974/7764584/433359 (16 885)27 (9427)Overall
0.00.00.79 (0.37 to
1.69)
1.03 (0.30 to
3.61)
75/49819/25057/47613/2088 (1106)4 (490)Diet
0.00.00.66 (0.53 to
0.83)
0.67 (0.46 to
0.99)
347/3015121/1189240/315390/130027 (6755)10 (2700)Physical activity
10.835.20.88 (0.72 to
1.07)
1.02 (0.79 to
1.32)
672/3858441/2608677/4135481/282527 (9342)14 (6355)Mixed approach
Hypertensive
disorders of
pregnancy:
21.524.20.85 (0.71 to
1.00)
0.95 (0.78 to
1.16)
592/6568423/4177559/7130432/458645 (14 849)22 (9618)Overall
38.035.80.57 (0.18 to
1.79)
0.59 (0.07 to
4.65)
49/33539/17923/32218/1615 (729)3 (397)Diet
0.06.00.68 (0.49 to
0.93)
0.74 (0.42 to
1.33)
147/235973/1195106/251355/124220 (5125)7 (2565)Physical activity
16.319.41.01 (0.87 to
1.17)*
1.05 (0.86 to
1.28)
407/4004322/2933430/4295359/318321 (9136)13 (6797)Mixed approach
Preterm birth:
8.717.30.92 (0.79 to
1.08)
0.94 (0.78 to
1.13)
443/6511345/5286414/6971332/571349 (14 339)32 (11 676)Overall
0.00.00.32 (0.14 to
0.70)
0.28 (0.08 to
0.96)
45/81935/65313/8199/6477 (1696)4 (1344)Diet
0.00.01.09 (0.84 to
1.41)
1.29 (0.90 to
1.85)
148/241073/1540160/243195/154123 (5149)13 (3249)Physical activity
32.30.00.92 (0.75 to
1.12)
0.91 (0.73 to
1.12)
256/3412243/3223241/3721228/352520 (7630)16 (7219)Mixed approach
Caesarean
section:
16.20.00.89 (0.83 to
0.96)
0.91 (0.83 to
0.99)
2440/63681506/39942373/68601525/438566 (18 041)32 (11 410)Overall
0.00.00.88 (0.65 to
1.17)
0.78 (0.50 to
1.22)
264/620149/539238/610117/5357 (1732)4 (1340)Diet
0.00.00.83 (0.73 to
0.95)
0.82 (0.67 to
1.01)
746/2547349/1161648/2646306/123032 (6587)13 (3046)Physical activity
21.917.60.92 (0.80 to
1.06)
0.95 (0.84 to
1.08)
1481/32861059/23791487/36041102/262028 (9858)16 (7160)Mixed approach
Offspring
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Table 4 (continued)
I2 (%)Odds ratio (95% CI)Control: event/No eventIntervention: event/No
event
No of studies (No of
women)
Outcomes
IPD and
non-IPD
IPDIPD and
non-IPD
IPDIPD and
non-IPD
IPDIPD and
non-IPD
IPDIPD and
non-IPD
IPD
Composite
outcome:
NA0.0NA0.94 (0.83 to
1.08)NA951/2851NA1007/3172NA18 (7981)
Overall
NA0.0NA0.71 (0.03 to
18.23)
NA48/132NA34/132NA2 (346)Diet
NA0.0NA0.99 (0.67 to
1.46)
NA143/498NA138/495NA5 (1274)Physical activity
NA4.7NA0.95 (0.81 to
1.11)
NA797/2317NA835/2545NA12 (6494)Mixed approach
Stillbirth†:
0.00.00.85 (0.24 to
3.02)
0.81 (<0.01 to
256.69)
14/224711/184112/22619/18584 (4534)2 (3719)Overall
Small for
gestational age:
0.00.01.05 (0.94 to
1.18)
1.06 (0.94 to
1.20)685/5461
632/5001
773/6018
709/532444 (12 937)33 (11 666)Overall
0.00.01.05 (0.62 to
1.77)
0.92 (0.45 to
1.88)55/77147/63956/74641/610
6 (1628)4 (1337)Diet
51.712.31.01 (0.83 to
1.24)
1.05 (0.84 to
1.34)271/1670232/1395274/1740243/1402
21 (3955)14 (3272)Physical activity
0.00.01.08 (0.93 to
1.27)
1.08 (0.92 to
1.28)386/3309370/3086443/3532425/3312
20 (7670)16 (7193)Mixed approach
Large for
gestational age:
41.038.00.86 (0.71 to
1.04)
0.90 (0.76 to
1.07)
833/5510759/5052820/6185744/549245 (13 348)34 (12 047)Overall
0.00.00.82 (0.54 to
1.22)
0.91 (0.60 to
1.37)
203/661176/548172/663155/5296 (1699)4 (1408)Diet
6.934.30.96 (0.67 to
1.37)
0.96 (0.59 to
1.54)
161/1768124/1528159/1842121/155721 (3930)15 (3330)Physical activity
4.351.00.83 (0.62 to
1.10)
0.89 (0.67 to
1.17)
523/3348481/3095489/3680468/340621 (8040)16 (7450)Mixed approach
Admission to
neonatal
intensive care
unit:
0.00.00.97 (0.82 to
1.14)
1.01 (0.84 to
1.23)
400/4149279/3586406/4543302/397321 (9498)16 (8140)Overall
0.0NA0.33 (<0.01 to
47.97)
NA‡29/17013/13611/1793/1372 (389)1 (289)Diet
0.020.80.79 (0.35 to
1.78)
0.77 (0.21 to
2.81)
43/57740/54334/58631/5524 (1240)3 (1166)Physical activity
0.00.01.05 (0.88 to
1.25)
1.10 (0.89 to
1.35)
332/3453230/3036360/3626268/328415 (7771)13 (6818)Mixed approach
*Recalculation using DerSimonian-Laird.
†All data come from studies with mixed approach interventions.
‡Not possible to estimate standard deviations.
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Table 5| Differential effects of diet and physical activity based interventions on maternal and offspring composite outcomes in subgroups
of pregnant women
Treatment covariate interactionOdds ratio* (95% CI)No of studies (No of women)Composite outcomes
I2 (%)Coefficient; 95% CI (95% PI)
Maternal
Baseline body mass index:
01.00; 0.98 to 1.02 (0.98 to 1.02)†0.91 (0.65 to 1.28)12 (2445)Normal
1.04 (0.86 to 1.26)19 (2222)Overweight
0.92 (0.80 to 1.05)20 (4181)Obese
Parity:
34.01.03; 0.75 to 1.39 (0.53 to 2.00)‡0.87 (0.71 to 1.07)21 (4613)Nulliparous
0.92 (0.78 to 1.07)22 (4186)Multiparous
Ethnicity:
00.93; 0.63 to 1.37 (0.62 to 1.38)§0.92 (0.79 to 1.07)15 (6510)White
0.86 (0.63 to 1.17)11 (917)Non-white
Age (years):
01.01; 0.99 to 1.03 (0.99 to 1.03)¶0.91 (0.81 to 1.02)24 (8656)≥20
1.57 (0.66 to 3.71)9 (172)<20
Pre-existing medical condition**:
24.91.44; 0.15 to 13.74 (0.03 to 76.75)††0.85 (0.66 to 1.09)15 (3135)None
1.65 (0.36 to 7.51)5 (89)≥1
Offspring
Baseline body mass index:
18.50.98; 0.95 to 1.00 (0.94 to 1.02)†0.93 (0.60 to 1.43)7 (1843)Normal
0.83 (0.61 to 1.13)12 (2065)Overweight
0.92 (0.72 to 1.19)13 (4327)Obese
Parity:
35.50.94; 0.64 to 1.37 (0.39 to 2.28)‡0.97 (0.80 to 1.17)16 (4152)Nulliparous
0.91 (0.72 to 1.15)15 (4048)Multiparous
Ethnicity:
01.12; 0.75 to 1.68 (0.74 to 1.69)§0.93 (0.79 to 1.08)11 (6018)White
1.10 (0.78 to 1.54)9 (939)Non-white
Age (years):
4.11.01; 0.98, 1.04 (0.97 to 1.05)¶0.95 (0.82 to 1.09)16 (8061)≥20
1.01 (0.34 to 2.98)7 (162)<20
Pre-existing medical condition**:
00.58; 0.03, 9.81 (<0.001 to 2440.15)††0.89 (0.74 to 1.08)12 (3407)None
0.54 (0.04 to 7.52)3 (63)≥1
PI=prediction interval.
*Model accounted for baseline weight and clustering effect.
†Per unit of body mass index.
‡Multiparous versus nulliparous.
§Non-white versus white.
¶Per year of age.
**Diabetes mellitus or hypertension.
††≥1 medical condition versus none.
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Figures
Fig 1 Identification and selection of studies in individual participant data (IPD) meta-analysis of diet and physical activity
based interventions on pregnancy outcomes after gestational weight gain
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Fig 2 Assessment of risk of bias in all eligible studies (n=103), studies with individual participant data (IPD) (n=36), and
studies without access to IPD (n=67)
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